Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Microbot Medical Inc. Director's Dealing 2017

Sep 25, 2017

33819_dirs_2017-09-25_e5205dac-2af3-4d8d-925b-cf61cbc49b1b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Microbot Medical Inc. (MBOT)
CIK: 0000883975
Period of Report: 2017-09-15

Reporting Person: Shoham Moshe (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-09-15 Common Stock S 74975 $1.25 Disposed 1592090 Direct
2017-09-15 Common Stock S 28657 $1.255 Disposed 1592090 Direct
2017-09-15 Common Stock S 40500 $1.26 Disposed 1592090 Direct
2017-09-15 Common Stock S 20276 $1.265 Disposed 1592090 Direct
2017-09-15 Common Stock S 400 $1.2675 Disposed 1592090 Direct
2017-09-15 Common Stock S 27384 $1.27 Disposed 1592090 Direct
2017-09-15 Common Stock S 1200 $1.275 Disposed 1592090 Direct
2017-09-15 Common Stock S 14400 $1.28 Disposed 1592090 Direct
2017-09-15 Common Stock S 11083 $1.285 Disposed 1592090 Direct
2017-09-15 Common Stock S 6463 $1.29 Disposed 1592090 Direct
2017-09-15 Common Stock S 9001 $1.295 Disposed 1592090 Direct
2017-09-15 Common Stock S 6500 $1.3 Disposed 1592090 Direct
2017-09-15 Common Stock S 1471 $1.305 Disposed 1592090 Direct
2017-09-15 Common Stock S 7490 $1.31 Disposed 1592090 Direct
2017-09-15 Common Stock S 200 $1.32 Disposed 1592090 Direct

Footnotes

F1: Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 250,000 shares of Issuer common stock on September 15, 2017. Accordingly, Reporting Person beneficially owned 1,592,090 shares of Issuer common stock following the reported transactions.